Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Biopsy Techniques and Primary Surgery for Melanoma
Description
Dr. Kelly Cha, an Associate Professor of Dermatology at the University of Michigan, presents on biopsy techniques and primary surgery for melanoma. She emphasizes the dual goals of melanoma biopsy: obtaining an accurate diagnosis and prognostic information while facilitating effective future treatment. Dr. Cha reviews the recommended biopsy techniques, primarily focusing on excisional biopsies (complete biopsies) with preferred narrow margins of 1-3mm, which can be performed using various methods like elliptical excision, punch excision, or saucerization shave removal. She illustrates common pitfalls associated with partial biopsies, which can lead to inaccurate Breslow depth assessment and mismanagement of the melanoma. Case studies highlight the importance of obtaining complete histologic data to guide treatment decisions. Additionally, Dr. Cha discusses the significance of photographing biopsy sites to reduce the risk of wrong site surgery and proposes best practices for site identification. She elaborates on surgical margins for melanoma excision, underscoring historical changes and current recommendations based on tumor depth, emphasizing the importance of balancing adequate margins against patient morbidity. The ongoing Melmart trial is noted, which investigates the impact of different excision margins on melanoma outcomes. Overall, the presentation highlights the critical role of proper biopsy techniques and meticulous surgical planning in the management of melanoma.
View moreConclusions
- Accurate biopsy techniques are essential for diagnosing melanoma and assessing prognostic parameters, particularly Breslow depth.
- Excisional biopsy with 1-3mm margins is the preferred technique for melanoma, allowing for accurate staging and future treatment planning.
- Partial biopsies should be avoided unless in specific cases where they are deemed necessary, as they may compromise staging accuracy.
- If a shave biopsy shows residual tumor at the base, a deeper biopsy should be performed immediately to obtain accurate Breslow depth.
- Biopsy technique does not appear to impact the risk of metastasis or local recurrence rates.
- Post-biopsy surgical margins should be defined based on the Breslow depth of the lesion, with specific recommendations provided for different thicknesses.
- For melanoma in situ, a margin of 1 cm is recommended, whereas invasive melanoma margins depend on thickness, with distances ranging from 1-2 cm or more as needed.
- Ongoing studies, such as the MelMarT trial, will help in defining the optimal surgical margins for melanoma management.
- Documentation and photographic records of biopsy sites are important to prevent wrong-site surgery and ensure accurate treatment.
- Swetter SM et al. Guidelines of Care for the Management of Primary Cutaneous Melanoma. J Am Acad Dermatol 2019;80:208-250.
- Karimipour DJ et al. Microstaging accuracy after subtotal incisional biopsy of cutaneous melanoma. J Am Acad Dermatol 2005;52:798-802.
- Martin RCG et al. Is incisional biopsy of melanoma harmful? Am J Surg 2005;190:913-917.
- Duarte AF et al. Dermatol Surg 2015;41:59-68.
- McGinness JL and Goldstein G. The value of preoperative biopsy-site photography for identifying cutaneous lesions. Dermatol Surg 2010;36:194-197.
- Beltrami EJ et al. Surface anatomy in dermatology: Part I-Clinical importance, diagnostic utility, and impact on medical management. JAAD. 2024;91:207-20.
- Navarrete-Dechent C et al. Human surface anatomy terminology for dermatology: a Delphi consensus from the International Skin Imaging Collaboration. JEADV 2020; 34: 2659-2663.
- Veronesi U et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. NEJM 1988;318:1159-62.
- Balch CM et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg 1993;218:262-7.
- Ross M and Gershenwald JE Evidence-based treatment of early-stage melanoma. J Surg Oncol 2011;104:341-353.